The ability of tacrolimus to inhibit both hapten-induced production of Th1 cytokines and the production of TNF-alpha by T cells and macrophages constitutes an effective rational for its use in the treatment of sarcoidosis [9]. This evidence concerns the gene TNF and sarcoidosis.